Spectrum Vascular: New Leadership to Spearhead Growth Post-SK Capital Investment
Company - People | Apr 14, 2025 | SK Capital
Spectrum Vascular, a medical device company specializing in vascular access and medication management, is set for a dynamic new chapter with the appointment of Ken Miller as CEO and Doug Shook as Chief Commercial Officer. These appointments are part of a strategy influenced by recent investment from SK Capital. Ken Miller, boasting over 35 years in the medical devices sector, has taken on the role of CEO with a vision to enhance patient outcomes and commercial performance. Simultaneously, Doug Shook, with his robust experience in commercial leadership in the medical technology industry, steps in as CCO to drive Spectrum’s market engagement. This transition is backed by SK Capital's strategy to enhance strategic positioning in life sciences, a domain it has heavily invested in. The investment by SK Capital in late March aligns with Spectrum’s mission to innovate and expand its market presence, especially in the field of healthcare-acquired infection prevention. Additionally, Event Capital Strategies collaborates with SK Capital to provide strategic support to advance Spectrum’s operational performance.
Sectors
- Medical Devices
- Private Equity
Geography
- United States – Spectrum Vascular and SK Capital are based in the United States, with Spectrum's new executive leadership and recent investment activity anchored in U.S. operations.
Industry
- Medical Devices – Spectrum Vascular operates in the medical device industry, providing vascular access and medication management products aimed at reducing healthcare-acquired infections.
- Private Equity – SK Capital, a private investment firm, recently invested in Spectrum Vascular, signaling its influence and interest in transforming the company's operational strategy and market positioning.
Financials
- Approximately $9 billion – SK Capital's current assets under management.
- Approximately $12 billion – Annual revenues generated by SK Capital's portfolio.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Spectrum Vascular | Target Company | Company | A medical device company focused on vascular access and medication management. |
| SK Capital | Private Equity Investor | Company | A private investment firm with a focus on the life sciences sector, it recently invested in Spectrum Vascular. |
| Ken Miller | Chief Executive Officer | Person | Newly appointed CEO of Spectrum Vascular, bringing over 35 years of industry experience. |
| Doug Shook | Chief Commercial Officer | Person | Newly appointed CCO of Spectrum Vascular with extensive commercial leadership experience. |
| Event Capital Strategies | Strategic Advisor | Company | A medical technology-focused investment firm providing strategic and functional support. |